Topics

Repertoire Immune Medicines Company Profile

13:55 EDT 6th April 2020 | BioPortfolio

Repertoire Immune Medicines, a Flagship Pioneering company, is a clinical stage biotechnology company working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions and infectious diseases. The company is founded on the premise that the repertoire of TCR-antigen codes that drive health and disease represents one of the greatest opportunities for innovation in medical science. The company harnesses and deploys the intrinsic ability of T cells to prevent and cure disease. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15. To learn more about Repertoire Immune Medicines, please visit our website: www.repertoire.com and follow us on LinkedIn.


News Articles [1097 Associated News Articles listed on BioPortfolio]

Repertoire Launches To Turn Immune System Insights Into T-Cell Therapies, Vaccines

Flagship Pioneering combined Torque Therapeutics and Cogen Immune Medicines, which have raised more than $220m, into Repertoire Immune Medicines with...    

Repertoire Immune Taps Torque Top Exec, Biogen Vet John Cox as CEO

Repertoire Immune Medicines, a Cambridge, MA-based biotech Flagship Pioneering formed by combining its companies Cogen Immune Medicines and Torque Therapeutics, named John Cox its CEO. Cox has been To...

Flagship combines two startups into cell therapy-focused Repertoire Immune Medicines

The life sciences investment firm is putting together Cogen Immune Medicines and Torque Therapeutics, the latter of which had a cell therapy candidate for cancers in the clinic already.

Flagship Pioneering Merges Sister Companies to Form Repertoire Immune Medicines

The new company is focused on tapping into the powers of the immune system to address numerous diseases.

Characterizing the BCR repertoire in immune-mediated diseases

Immune and TRG repertoire signature of the thymus in Down syndrome patients

Analysis of the B cell receptor repertoire in six immune-mediated diseases

Global Immune Repertoire Sequencing Market Size study, by Type Assay Kits, Software Services, by Application Biomarker Discovery, Infectious Diseases, Vaccine Development Efficacy, Cancer Immunotherapy, Autoimmune Diseases, Transplant Rejection Toleran

Global Immune Repertoire Sequencing Market to reach USD XX billion by 2025.Global Immune Repertoire Sequencing Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy ...

PubMed Articles [2042 Associated PubMed Articles listed on BioPortfolio]

ImSpectR - R package to quantify immune repertoire diversity in spectratype and repertoire sequencing data.

An effective immune system is characterized by a diverse immune repertoire. There is a strong demand for accurate and quantitative methods to assess the diversity of the immune repertoire for various ...

Distinct immune characteristics distinguish hereditary and idiopathic chronic pancreatitis.

Chronic pancreatitis (CP) is considered an irreversible fibroinflammatory pancreatic disease. Despite numerous animal model studies, questions remain about local immune characteristics in human CP. We...

Australian pharmacists: ready for increased non-prescription medicines reclassification.

Reclassification of medicines from prescription to non-prescription increases timely access to treatment, promotes self-management of minor ailments and relieves healthcare system burden. Previous res...

Identifying the most effective essential medicines policies for quality use of medicines: A replicability study using three World Health Organisation data-sets.

Poor quality use of medicines (QUM) has adverse outcomes. Governments' implementation of essential medicines (EM) policies is often suboptimal and there is limited information on which policies are mo...

Understanding the human antibody repertoire.

The origins of the various elements in the human antibody repertoire have been and still are subject to considerable uncertainty. Uncertainty in respect of whether the various elements have always ser...

Clinical Trials [4347 Associated Clinical Trials listed on BioPortfolio]

A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients

This study is designed to evaluate the untreated NSCLC patients. After participants have accepted chemotherapy, radiotherapy, and immunotherapy, the investigators used the next generation ...

Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire

To analyze the proportion of hereditary tumors in ovarian cancer patients in China, as well as the spectrum of variations; the ctDNA characteristics in patients with ovarian cancer; the co...

Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant

This research trial studies characterization of T-cell repertoire through next-generation sequencing in patients with acute myeloid leukemia undergoing stem cell transplant. Characterizing...

Immune Profiling in Multiple Myeloma

This study propose to investigate the immune repertoire of MM patients at the time of diagnosis vs. 1st vs. 2nd vs. 3rd relapse. This study will provide insights into the immune status of ...

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

The aim of this trial is to find out if immune responses to HIV can be boosted in individuals who start medicines soon after being infected. If immune responses can be boosted to the viru...

Companies [1201 Associated Companies listed on BioPortfolio]

Repertoire Immune Medicines

Repertoire Immune Medicines, a Flagship Pioneering company, is a clinical stage biotechnology company working to unleash the remarkable power of the human immune system to prevent, treat or cure canc...

Atreca, Inc.

Atreca, Inc., is a privately held biopharmaceutical company with an immune repertoire capture technology that revolutionizes the discovery and development of a wide range of produ...

Amazon Biotech

Amazon Biotech (OTCBB: AMZB) was established in 2003 to focus on the research and development of novel all-natural drugs for a better quality of life, by using the best of traditional medicines from...

Rheos Medicines

Rheos Medicines is a biopharmaceutical company harnessing insights in immunometabolism to develop novel therapeutics for patients with severe autoimmune disorders, inflamma...

ImmunID

ImmunID is pioneering the field of molecular immune diagnostics since 2005, offering two commercial products. Its proprietary CE-marked flagship product ImmunTraCkeR evaluates the...

More Information about "Repertoire Immune Medicines" on BioPortfolio

We have published hundreds of Repertoire Immune Medicines news stories on BioPortfolio along with dozens of Repertoire Immune Medicines Clinical Trials and PubMed Articles about Repertoire Immune Medicines for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Repertoire Immune Medicines Companies in our database. You can also find out about relevant Repertoire Immune Medicines Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record